Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:55 pm Unchanged | 2026-03-13 | 13G | Vir Biotechnology, Inc. VIR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2026-03-03 5:00 pm Purchase | 2026-02-27 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 13,534,704 8.500% | 13,534,704 (New Position) | Filing History |
| 2026-02-17 5:00 pm Purchase | 2025-12-31 | 13G | Vir Biotechnology, Inc. VIR | SB INVESTMENT ADVISERS (UK) LTD | 13,116,977 9.400% | 13,116,977 (New Position) | Filing History |
| 2025-04-28 1:02 pm Purchase | 2025-03-31 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 14,826,039 10.800% | 14,826,039 (New Position) | Filing History |
| 2024-10-18 12:29 pm Unchanged | 2024-10-18 | 13G | Vir Biotechnology, Inc. VIR | STATE STREET CORP STT | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 5:17 pm Unchanged | 2024-02-13 | 13G | Vir Biotechnology, Inc. VIR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-13 5:00 pm Unchanged | 2024-02-13 | 13G | Vir Biotechnology, Inc. VIR | SB INVESTMENT ADVISERS (UK) LTD | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-24 07:59 am Unchanged | 2024-01-24 | 13G | Vir Biotechnology, Inc. VIR | STATE STREET CORP STT | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-01-23 4:14 pm Unchanged | 2024-01-23 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-14 4:07 pm Unchanged | 2023-02-14 | 13G | Vir Biotechnology, Inc. VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 11:35 am Unchanged | 2023-02-09 | 13G | Vir Biotechnology, Inc. VIR | VANGUARD GROUP INC | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-24 1:56 pm Unchanged | 2023-01-24 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-13 3:45 pm Unchanged | 2022-09-13 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-08 1:43 pm Unchanged | 2022-09-08 | 13G | Vir Biotechnology, Inc. VIR | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-10 5:05 pm Purchase | 2021-12-20 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 19,189,094 14.700% | 3,374 (+0.02%) | Filing History |
| 2022-02-14 4:05 pm Sale | 2021-12-31 | 13G | Vir Biotechnology, Inc. VIR | SCANGOS GEORGE A | 6,266,581 4.790% | -734,727 (-10.49%) | Filing History |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | Vir Biotechnology, Inc. VIR | Capital International Investors | 5,634,019 4.300% | -5,806,552 (-50.75%) | Filing History |
| 2022-02-10 4:46 pm Purchase | 2021-12-31 | 13G | Vir Biotechnology, Inc. VIR | GLAXOSMITHKLINE PLC | 8,550,954 6.500% | 1,924,927 (+29.05%) | Filing History |
| 2022-02-10 08:42 am Purchase | 2021-12-31 | 13G | Vir Biotechnology, Inc. VIR | VANGUARD GROUP INC | 7,330,131 5.600% | 7,330,131 (New Position) | Filing History |
| 2022-01-10 5:02 pm Sale | 2021-12-20 | 13D | Vir Biotechnology, Inc. VIR | ARCH Venture Fund IX L.P. | 19,185,720 14.700% | -2,589,653 (-11.89%) | Filing History |